These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 38958473)
21. The re-emerging role of microbial natural products in antibiotic discovery. Genilloud O Antonie Van Leeuwenhoek; 2014 Jul; 106(1):173-88. PubMed ID: 24923558 [TBL] [Abstract][Full Text] [Related]
22. Synthetic biology for pharmaceutical drug discovery. Trosset JY; Carbonell P Drug Des Devel Ther; 2015; 9():6285-302. PubMed ID: 26673570 [TBL] [Abstract][Full Text] [Related]
23. The relationship between target-class and the physicochemical properties of antibacterial drugs. Mugumbate G; Overington JP Bioorg Med Chem; 2015 Aug; 23(16):5218-24. PubMed ID: 25975639 [TBL] [Abstract][Full Text] [Related]
24. (Dis)similar Analogues of Riboswitch Metabolites as Antibacterial Lead Compounds. Matzner D; Mayer G J Med Chem; 2015 Apr; 58(8):3275-86. PubMed ID: 25603286 [TBL] [Abstract][Full Text] [Related]
25. Recent Progress in Natural-Product-Inspired Programs Aimed To Address Antibiotic Resistance and Tolerance. Abouelhassan Y; Garrison AT; Yang H; Chávez-Riveros A; Burch GM; Huigens RW J Med Chem; 2019 Sep; 62(17):7618-7642. PubMed ID: 30951303 [TBL] [Abstract][Full Text] [Related]
26. Hybrid combinations containing natural products and antimicrobial drugs that interfere with bacterial and fungal biofilms. Zacchino SA; Butassi E; Cordisco E; Svetaz LA Phytomedicine; 2017 Dec; 37():14-26. PubMed ID: 29174600 [TBL] [Abstract][Full Text] [Related]
27. Current landscape in the discovery of novel antibacterial agents. Vila J; Moreno-Morales J; Ballesté-Delpierre C Clin Microbiol Infect; 2020 May; 26(5):596-603. PubMed ID: 31574341 [TBL] [Abstract][Full Text] [Related]
28. Bacterial genome engineering and synthetic biology: combating pathogens. Krishnamurthy M; Moore RT; Rajamani S; Panchal RG BMC Microbiol; 2016 Nov; 16(1):258. PubMed ID: 27814687 [TBL] [Abstract][Full Text] [Related]
29. Decoding the Structural Diversity: A New Horizon in Antimicrobial Prospecting and Mechanistic Investigation. Qiu Z; Huang R; Wu Y; Li X; Sun C; Ma Y Microb Drug Resist; 2024 Jun; 30(6):254-272. PubMed ID: 38648550 [TBL] [Abstract][Full Text] [Related]
30. A metabolic network approach for the identification and prioritization of antimicrobial drug targets. Chavali AK; D'Auria KM; Hewlett EL; Pearson RD; Papin JA Trends Microbiol; 2012 Mar; 20(3):113-23. PubMed ID: 22300758 [TBL] [Abstract][Full Text] [Related]
31. Antibacterial natural products in medicinal chemistry--exodus or revival? von Nussbaum F; Brands M; Hinzen B; Weigand S; Häbich D Angew Chem Int Ed Engl; 2006 Aug; 45(31):5072-129. PubMed ID: 16881035 [TBL] [Abstract][Full Text] [Related]
32. How to translate a bioassay into a screening assay for natural products: general considerations and implementation of antimicrobial screens. Fallarero A; Hanski L; Vuorela P Planta Med; 2014 Sep; 80(14):1182-99. PubMed ID: 25221978 [TBL] [Abstract][Full Text] [Related]
33. Potential of marine natural products against drug-resistant bacterial infections. Liu M; El-Hossary EM; Oelschlaeger TA; Donia MS; Quinn RJ; Abdelmohsen UR Lancet Infect Dis; 2019 Jul; 19(7):e237-e245. PubMed ID: 31031171 [TBL] [Abstract][Full Text] [Related]
34. Strategies for the Discovery and Development of New Antibiotics from Natural Products: Three Case Studies. Herrmann J; Lukežič T; Kling A; Baumann S; Hüttel S; Petković H; Müller R Curr Top Microbiol Immunol; 2016; 398():339-363. PubMed ID: 27738913 [TBL] [Abstract][Full Text] [Related]